The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 04, 2025

Filed:

Jun. 24, 2022
Applicants:

Vascuros Medical (Shanghai) Co., Ltd., Shanghai, CN;

Vascuros Medical Pte Ltd., Jtc Medtech Hub, SG;

Inventors:

Jingnan Luo, Medtech Hub, SG;

Qian Yi Michele Lee, Medtech Hub, SG;

Honglei Wang, Medtech Hub, SG;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/00 (2006.01); A61K 31/337 (2006.01); A61K 31/436 (2006.01); A61L 29/08 (2006.01); A61L 29/16 (2006.01); A61M 25/10 (2013.01);
U.S. Cl.
CPC ...
A61L 29/16 (2013.01); A61K 31/337 (2013.01); A61K 31/436 (2013.01); A61L 29/085 (2013.01); A61M 25/1029 (2013.01); A61L 2300/416 (2013.01); A61L 2300/62 (2013.01); A61L 2300/622 (2013.01); A61L 2300/624 (2013.01); A61L 2420/02 (2013.01); A61M 2025/1004 (2013.01); A61M 2025/1031 (2013.01); A61M 2025/105 (2013.01); A61M 2025/1075 (2013.01);
Abstract

Disclosed herein is a drug-coated medical device in the form of a balloon having an inner surface and an outer hydrophobic surface, an adhesion balance layer directly on the outer hydrophobic surface of the balloon, comprising a hydrophilic polymer and/or a hydrophilic compound where the hydrophilic compound has a molecular weight of less than 1,000 Daltons, and a therapeutic layer directly on the adhesion balance layer comprising a therapeutic agent and a pharmaceutically acceptable carrier, wherein the therapeutic agent is a hydrophobic therapeutic agent with one or more hydrogen-bonding groups and is provided as discrete drug particles in the therapeutic layer, the drug particles have at least one dimension that is less than 25 μm and are uniformly distributed on the surface of the balloon, and the pharmaceutically acceptable carrier is hydrophilic and has a molecular weight of less than 1,000 Daltons. A process to make the drug-coated medical device and uses thereof are also disclosed.


Find Patent Forward Citations

Loading…